17 да се категоризират като нечести (≥ 1/ 1000 до ≤ 1/ 100) или редки (≥ 1/ 10, 000 до ≤ 1/ 1000).
The frequency of adverse reactions reported in association with BeneFIX would be categorized as uncommon (≥ 1/ 1000 to ≤ 1/ 100) or rare (≥ 1/ 10,000 to ≤ 1/ 1000).